Stephen Butts is currently the co-founder of Arrivo BioVentures, LLC, a drug development company located in Morrisville, NC and CEO of Arrivo Management LLC. Mr. Butts’ has a track record of successful fund raising, product licensing and M&A with start-ups in the pharma/biotech industry. He has nearly 25 years of experience in the pharmaceutical and biotech industry as an executive as well as various commercial roles including brand leadership, new product planning, business development and sales management. Prior to Arrivo, he was co-founder, President and COO of Aerial BioPharma LLC, a drug development company that sold its lead drug for narcolepsy to Jazz Pharmaceuticals in 2014. Prior to Aerial, Mr. Butts was co-founder and Executive Vice President of Neuronex Inc, a successful drug development company focused on developing treatments for patients with certain seizure disorders. Acorda Therapeutics acquired Neuronex in December 2012. Additionally, he was an original member of the executive team at Addrenex Pharmaceuticals, a specialty pharmaceutical development company. Mr. Butts served as Vice President of Commercial Operations and played a key role in the company’s sale to Shionogi Pharma in 2009. He has also served as Vice President of Sales & Marketing at BioBehavioral Diagnostics Company, as well as assignments at Eli Lilly and Company and Braintree Laboratories.
Mr. Butts is currently the Chairman of the Board of Directors of EnviCor Enterprises LLC, a manufacturing company located in Smithfield, NC, focused on developing products for the restaurant industry. He is also a member of the Board of Directors for Otologic Pharmaceutics, a privately held pharmaceutical company focused on the development of products to treat and prevent hearing loss. Mr. Butts serves on two not-for-profit boards. He is a member of the Board of Advisors of the Morehead Planetarium at UNC-Chapel Hill and Board of Directors of the Triangle Futbol Club Alliance, a not-for-profit youth soccer club.
Mr. Butts holds a BS degree in Business Administration and an MBA from the Kenan-Flagler School of Business at UNC-Chapel Hill.
See Steve live as a Speaker at CED Life Science Conference 2017